clorazepate ๐Ÿถ Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
diazepam derivatives 711 57109-90-7

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • clorazepate monopotassium
  • clorazepate potassium
  • clorazepic acid
  • clorazepate
  • chlorazepate
  • clorazepate dipotassium
  • dipotassium clorazepate
  • potassium clorazepate
A water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions.
  • Molecular weight: 314.73
  • Formula: C16H11ClN2O3
  • CLOGP: 2.51
  • LIPINSKI: 0
  • HAC: 5
  • HDO: 2
  • TPSA: 78.76
  • ALOGS: -4.10
  • ROTB: 2

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
20 mg O

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 1 Benet LZ, Broccatelli F, Oprea TI
EoM (Fraction excreted unchanged in urine) 0.50 % Benet LZ, Broccatelli F, Oprea TI
MRTD (Maximum Recommended Therapeutic Daily Dose) 5.45 ยตM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
BA (Bioavailability) 91 % Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H
Vd (Volume of distribution) 0.20 L/kg Lombardo F, Berellini G, Obach RS
CL (Clearance) 1.10 mL/min/kg Lombardo F, Berellini G, Obach RS
t_half (Half-life) 2.40 hours Lombardo F, Berellini G, Obach RS
S (Water solubility) 100 mg/mL Bocci G, Oprea TI, Benet LZ

Approvals:

DateAgencyCompanyOrphan
June 23, 1972 FDA RECORDATI RARE

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Coma 224.61 17.88 133 9521 64231 63415137
Suicide attempt 112.97 17.88 85 9569 60833 63418535
Coma blister 107.59 17.88 19 9635 141 63479227
Somnolence 93.44 17.88 125 9529 178560 63300808
Drug abuse 78.11 17.88 74 9580 72444 63406924
Disorientation 75.22 17.88 56 9598 39396 63439972
Seizure 71.14 17.88 94 9560 132540 63346828
Erythrodermic psoriasis 67.78 17.88 18 9636 1000 63478368
Neurological decompensation 66.53 17.88 22 9632 2616 63476752
Poisoning deliberate 66.52 17.88 33 9621 11185 63468183
Toxic epidermal necrolysis 64.67 17.88 43 9611 25291 63454077
Rhabdomyolysis 61.48 17.88 52 9602 43899 63435469
Drug interaction 61.15 17.88 118 9536 229013 63250355
Tissue infiltration 60.94 17.88 15 9639 614 63478754
Overdose 60.83 17.88 81 9573 114997 63364371
Basal ganglion degeneration 60.64 17.88 14 9640 434 63478934
Dermatitis exfoliative 57.60 17.88 24 9630 5435 63473933
Fall 57.04 17.88 159 9495 392175 63087193
Antithrombin III 55.81 17.88 11 9643 156 63479212
Behaviour disorder 51.14 17.88 19 9635 3180 63476188
Uterine enlargement 50.52 17.88 15 9639 1253 63478115
Stupor 49.20 17.88 20 9634 4255 63475113
Hyperventilation 48.55 17.88 22 9632 6094 63473274
Monoplegia 47.49 17.88 18 9636 3183 63476185
Euphoric mood 46.62 17.88 20 9634 4867 63474501
Anaesthesia 45.32 17.88 11 9643 424 63478944
Intentional overdose 45.13 17.88 56 9598 74096 63405272
Hyperthyroidism 45.10 17.88 28 9626 14645 63464723
Toxicity to various agents 44.89 17.88 109 9545 247141 63232227
Depressed level of consciousness 44.56 17.88 51 9603 62027 63417341
Electrolyte imbalance 43.95 17.88 31 9623 20045 63459323
Inguinal hernia 43.74 17.88 15 9639 1992 63477376
Loss of consciousness 43.32 17.88 70 9584 118051 63361317
Multiple organ dysfunction syndrome 43.08 17.88 48 9606 56704 63422664
Psychogenic seizure 42.22 17.88 14 9640 1678 63477690
Drug monitoring procedure incorrectly performed 36.30 17.88 8 9646 200 63479168
Psychomotor hyperactivity 34.43 17.88 21 9633 10642 63468726
Cholecystitis 34.25 17.88 24 9630 15353 63464015
Joint swelling 33.43 17.88 5 9649 327661 63151707
Hypochromic anaemia 32.76 17.88 12 9642 1930 63477438
Drug dependence 32.25 17.88 28 9626 24455 63454913
Delusion 32.12 17.88 21 9633 11996 63467372
Dysaesthesia 32.08 17.88 15 9639 4463 63474905
Neuroleptic malignant syndrome 32.06 17.88 21 9633 12035 63467333
Sudden cardiac death 31.62 17.88 12 9642 2128 63477240
Klebsiella infection 30.59 17.88 18 9636 8548 63470820
Granulomatous liver disease 30.11 17.88 9 9645 769 63478599
Intra-abdominal haematoma 29.88 17.88 11 9643 1794 63477574
Mydriasis 29.80 17.88 20 9634 11936 63467432
Urinary retention 28.99 17.88 29 9625 30272 63449096
Anterograde amnesia 28.62 17.88 8 9646 539 63478829
Intervertebral disc disorder 27.98 17.88 14 9640 4829 63474539
Eosinophilia 27.92 17.88 25 9629 22731 63456637
Drug withdrawal syndrome 27.82 17.88 27 9627 27167 63452201
Social avoidant behaviour 27.75 17.88 12 9642 2976 63476392
Serotonin syndrome 26.61 17.88 27 9627 28655 63450713
Abdominal discomfort 26.41 17.88 8 9646 320877 63158491
Respiratory disorder 26.18 17.88 31 9623 39051 63440317
Derailment 26.14 17.88 5 9649 60 63479308
Confusional state 25.98 17.88 87 9567 236293 63243075
Tremor 25.78 17.88 60 9594 132179 63347189
Drug ineffective 25.72 17.88 78 9576 1044687 62434681
Hyperpyrexia 25.50 17.88 12 9642 3620 63475748
Rash 25.17 17.88 29 9625 560842 62918526
Disturbance in attention 25.10 17.88 30 9624 38159 63441209
Intestinal villi atrophy 24.41 17.88 6 9648 244 63479124
Hyperammonaemia 24.12 17.88 13 9641 5219 63474149
Abdominal tenderness 23.63 17.88 15 9639 8151 63471217
Somatic delusion 23.57 17.88 7 9647 585 63478783
Livedo reticularis 23.35 17.88 10 9644 2422 63476946
Catatonia 23.12 17.88 12 9642 4465 63474903
Pain 23.05 17.88 49 9605 740579 62738789
Arthropathy 23.00 17.88 4 9650 234788 63244580
Conversion disorder 22.89 17.88 9 9645 1755 63477613
Transaminases increased 22.89 17.88 26 9628 31341 63448027
Swelling 22.42 17.88 7 9647 275371 63203997
Hyponatraemia 22.06 17.88 51 9603 111849 63367519
Alopecia 21.97 17.88 12 9642 337524 63141844
Cyanosis 21.56 17.88 19 9635 16916 63462452
Nasopharyngitis 21.54 17.88 6 9648 254251 63225117
Suicidal ideation 21.52 17.88 36 9618 62385 63416983
Neonatal aspiration 21.50 17.88 5 9649 160 63479208
Cutaneous vasculitis 21.29 17.88 12 9642 5257 63474111
Hypersensitivity 21.19 17.88 9 9645 292676 63186692
Regressive behaviour 20.88 17.88 5 9649 182 63479186
Renal cyst 20.46 17.88 15 9639 10287 63469081
Lung disorder 20.26 17.88 35 9619 62226 63417142
Colitis ischaemic 19.95 17.88 15 9639 10693 63468675
Shock 19.81 17.88 21 9633 23442 63455926
Hyperthermia 19.71 17.88 14 9640 9142 63470226
Dysarthria 19.43 17.88 28 9626 42683 63436685
Irritability 19.37 17.88 24 9630 31670 63447698
Renal failure 19.33 17.88 50 9604 117602 63361766
Withdrawal syndrome 18.87 17.88 19 9635 19978 63459390
Hepatocellular injury 18.80 17.88 22 9632 27359 63452009
Fatigue 18.61 17.88 71 9583 887957 62591411
Infection 18.34 17.88 6 9648 229167 63250201

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Coma 145.12 18.42 89 5256 45589 34905997
Hepatitis acute 72.04 18.42 31 5314 7570 34944016
Somnolence 47.80 18.42 71 5274 111045 34840541
Anticoagulation drug level above therapeutic 46.76 18.42 16 5329 2100 34949486
Wrong patient 44.49 18.42 9 5336 146 34951440
Stevens-Johnson syndrome 43.54 18.42 30 5315 18609 34932977
Toxic epidermal necrolysis 41.73 18.42 31 5314 21615 34929971
Wrong patient received product 39.58 18.42 15 5330 2639 34948947
Tachycardia 37.62 18.42 55 5290 84717 34866869
Aggression 36.62 18.42 37 5308 38927 34912659
Pneumonia aspiration 36.15 18.42 38 5307 41865 34909721
Acute respiratory distress syndrome 34.70 18.42 30 5315 25939 34925647
Cor pulmonale acute 33.95 18.42 8 5337 270 34951316
Prothrombin level decreased 30.78 18.42 10 5335 1118 34950468
Extrapyramidal disorder 30.71 18.42 21 5324 12859 34938727
Faecal vomiting 30.26 18.42 8 5337 434 34951152
Rhabdomyolysis 29.90 18.42 44 5301 68119 34883467
Agitation 28.03 18.42 39 5306 57360 34894226
Restlessness 27.29 18.42 26 5319 25456 34926130
Dyspnoea 26.98 18.42 12 5333 376770 34574816
Pancreatitis acute 26.94 18.42 27 5318 28114 34923472
Drug interaction 26.32 18.42 85 5260 225861 34725725
Asphyxia 26.02 18.42 15 5330 6820 34944766
Dermatitis bullous 25.85 18.42 15 5330 6907 34944679
Toxic skin eruption 25.81 18.42 18 5327 11367 34940219
Blister 25.78 18.42 24 5321 22834 34928752
Sedation 25.53 18.42 23 5322 20983 34930603
Overdose 25.44 18.42 48 5297 91011 34860575
Clonus 25.34 18.42 11 5334 2739 34948847
Mucosal erosion 25.15 18.42 8 5337 836 34950750
Abnormal behaviour 23.98 18.42 24 5321 24945 34926641
Lung disorder 23.93 18.42 28 5317 34668 34916918
Miosis 23.81 18.42 16 5329 9519 34942067
Hypothermia 22.08 18.42 16 5329 10732 34940854
Intestinal obstruction 22.03 18.42 22 5323 22800 34928786
Cardio-respiratory arrest 21.84 18.42 34 5311 55239 34896347
Urinary retention 21.31 18.42 27 5318 36261 34915325
Eosinophilia 21.22 18.42 23 5322 26199 34925387
Cytotoxic oedema 21.01 18.42 5 5340 176 34951410
Intentional product misuse 20.79 18.42 30 5315 45581 34906005
Intentional overdose 20.31 18.42 29 5316 43645 34907941
Electromyogram abnormal 20.26 18.42 4 5341 57 34951529
Disturbance in attention 19.68 18.42 22 5323 25923 34925663
Colitis ischaemic 18.94 18.42 12 5333 6463 34945123
Wrong product administered 18.45 18.42 11 5334 5323 34946263

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Coma 350.84 16.99 213 12793 100436 79630946
Somnolence 133.61 16.99 179 12827 238802 79492580
Suicide attempt 111.87 16.99 99 12907 82833 79648549
Toxic epidermal necrolysis 100.51 16.99 72 12934 44509 79686873
Coma blister 98.49 16.99 19 12987 222 79731160
Disorientation 74.94 16.99 70 12936 62706 79668676
Poisoning deliberate 73.62 16.99 43 12963 18785 79712597
Rhabdomyolysis 72.98 16.99 87 12919 103044 79628338
Overdose 72.40 16.99 117 12889 184089 79547293
Drug interaction 71.22 16.99 187 12819 414996 79316386
Intentional overdose 63.12 16.99 82 12924 105878 79625504
Drug abuse 62.10 16.99 102 12904 162589 79568793
Hepatitis acute 62.10 16.99 36 12970 15506 79715876
Neurological decompensation 56.86 16.99 24 12982 5229 79726153
Erythrodermic psoriasis 56.81 16.99 18 12988 1740 79729642
Stupor 53.76 16.99 25 12981 6847 79724535
Toxicity to various agents 51.24 16.99 168 12838 421372 79310010
Depressed level of consciousness 50.23 16.99 70 12936 96582 79634800
Basal ganglion degeneration 49.29 16.99 12 12994 436 79730946
Tissue infiltration 48.84 16.99 13 12993 678 79730704
Seizure 48.76 16.99 100 12906 188734 79542648
Aggression 46.31 16.99 49 12957 50909 79680473
Dermatitis exfoliative 45.71 16.99 26 12980 10803 79720579
Urinary retention 45.45 16.99 51 12955 56579 79674803
Uterine enlargement 45.33 16.99 13 12993 895 79730487
Disturbance in attention 42.92 16.99 47 12959 50754 79680628
Eosinophilia 41.91 16.99 44 12962 45301 79686081
Pneumonia aspiration 41.70 16.99 53 12953 66914 79664468
Euphoric mood 39.36 16.99 21 12985 7705 79723677
Monoplegia 39.21 16.99 17 12989 3954 79727428
Hyperventilation 38.92 16.99 21 12985 7878 79723504
Faecal vomiting 38.37 16.99 12 12994 1112 79730270
Fall 38.23 16.99 169 12837 487460 79243922
Anaesthesia 37.66 16.99 10 12996 517 79730865
Behaviour disorder 37.43 16.99 19 12987 6294 79725088
Neuroleptic malignant syndrome 37.32 16.99 33 12973 27526 79703856
Confusional state 37.03 16.99 125 12881 317872 79413510
Lung disorder 36.95 16.99 55 12951 80502 79650880
Drug dependence 36.68 16.99 39 12967 40730 79690652
Joint swelling 35.89 16.99 3 13003 288643 79442739
Psychogenic seizure 35.69 16.99 13 12993 1918 79729464
Colitis ischaemic 35.04 16.99 25 12981 15334 79716048
Hyperthyroidism 34.97 16.99 29 12977 22180 79709202
Drug withdrawal syndrome 34.45 16.99 35 12971 34683 79696699
Anticoagulation drug level above therapeutic 34.12 16.99 15 12991 3605 79727777
Prothrombin level decreased 33.89 16.99 12 12994 1632 79729750
Sedation 32.19 16.99 41 12965 51854 79679528
Miosis 32.17 16.99 24 12982 15765 79715617
Tachycardia 31.32 16.99 81 12925 177687 79553695
Anterograde amnesia 30.54 16.99 9 12997 682 79730700
Antithrombin III 29.90 16.99 6 13000 87 79731295
Drug monitoring procedure incorrectly performed 29.05 16.99 8 12998 475 79730907
Sudden cardiac death 28.88 16.99 15 12991 5210 79726172
Psychomotor skills impaired 28.85 16.99 15 12991 5222 79726160
Psychomotor hyperactivity 28.63 16.99 23 12983 16826 79714556
Cardio-respiratory arrest 28.61 16.99 58 12948 108452 79622930
Wrong patient received product 27.68 16.99 14 12992 4604 79726778
Intervertebral disc disorder 27.10 16.99 14 12992 4811 79726571
Fatigue 27.01 16.99 71 12935 929656 78801726
Wrong patient 26.38 16.99 7 12999 361 79731021
Shock 26.37 16.99 34 12972 43514 79687868
Irritability 26.30 16.99 33 12973 41111 79690271
Cor pulmonale acute 26.16 16.99 8 12998 688 79730694
Wrong product administered 26.10 16.99 17 12989 8995 79722387
Pancreatitis acute 25.86 16.99 36 12970 49568 79681814
Multiple organ dysfunction syndrome 25.66 16.99 59 12947 120187 79611195
Mydriasis 25.64 16.99 22 12984 17621 79713761
Electrolyte imbalance 25.09 16.99 28 12978 30853 79700529
Restlessness 24.63 16.99 34 12972 46458 79684924
Lymphocytosis 24.59 16.99 13 12993 4680 79726702
Derailment 24.51 16.99 5 13001 79 79731303
Social avoidant behaviour 24.28 16.99 13 12993 4801 79726581
Intra-abdominal haematoma 24.12 16.99 11 12995 2880 79728502
Loss of consciousness 24.09 16.99 71 12935 167872 79563510
Respiratory disorder 24.06 16.99 33 12973 44823 79686559
Serotonin syndrome 23.96 16.99 33 12973 44994 79686388
Agitation 23.60 16.99 51 12955 99664 79631718
Hyponatraemia 23.46 16.99 73 12933 177775 79553607
Livedo reticularis 23.31 16.99 12 12994 4091 79727291
Inguinal hernia 23.22 16.99 14 12992 6474 79724908
Cholecystitis 23.15 16.99 23 12983 22189 79709193
Mucosal erosion 23.14 16.99 10 12996 2308 79729074
Withdrawal syndrome 22.94 16.99 25 12981 26829 79704553
Delusion 22.88 16.99 22 12984 20401 79710981
Stevens-Johnson syndrome 22.81 16.99 30 12976 39136 79692246
Hypothermia 22.69 16.99 23 12983 22723 79708659
Pain 22.57 16.99 51 12955 703751 79027631
Dysaesthesia 21.92 16.99 13 12993 5835 79725547
Conversion disorder 21.81 16.99 9 12997 1852 79729530
Somatic delusion 21.75 16.99 7 12999 711 79730671
Metabolic acidosis 21.61 16.99 44 12962 82485 79648897
Electromyogram abnormal 21.59 16.99 5 13001 146 79731236
Hypochromic anaemia 21.49 16.99 10 12996 2741 79728641
Hepatocellular injury 21.11 16.99 32 12974 47561 79683821
Granulomatous liver disease 21.06 16.99 8 12998 1325 79730057
Extrapyramidal disorder 20.94 16.99 22 12984 22657 79708725
Regressive behaviour 20.80 16.99 5 13001 172 79731210
Peripheral swelling 20.74 16.99 9 12997 269608 79461774
Arthralgia 20.37 16.99 39 12967 571764 79159618
Nasopharyngitis 20.30 16.99 8 12998 253873 79477509
Intestinal villi atrophy 20.25 16.99 6 13000 463 79730919
Rash maculo-papular 19.81 16.99 34 12972 56044 79675338
Coma scale abnormal 19.51 16.99 14 12992 8664 79722718
Toxic skin eruption 19.47 16.99 21 12985 22272 79709110
Catatonia 19.39 16.99 14 12992 8742 79722640
Salivary hypersecretion 19.19 16.99 17 12989 14207 79717175
Dermatitis bullous 19.17 16.99 17 12989 14228 79717154
Renal failure 19.10 16.99 74 12932 200894 79530488
Lipase increased 18.94 16.99 18 12988 16448 79714934
Swelling 18.74 16.99 6 13000 216705 79514677
Abnormal behaviour 18.34 16.99 26 12980 36395 79694987
Bradycardia 18.20 16.99 56 12950 135501 79595881
Agranulocytosis 18.19 16.99 29 12977 45001 79686381
Treatment failure 18.15 16.99 3 13003 170483 79560899
Disease progression 18.03 16.99 4 13002 184358 79547024
Asphyxia 17.82 16.99 15 12991 11705 79719677
Klebsiella infection 17.73 16.99 17 12989 15703 79715679
Sinusitis 17.65 16.99 5 13001 195496 79535886
Dysarthria 17.64 16.99 36 12970 67586 79663796
Sudden death 17.59 16.99 20 12986 22491 79708891
Hyperthermia 17.56 16.99 18 12988 18019 79713363
Tremor 17.30 16.99 64 12942 170019 79561363
Abdominal tenderness 17.02 16.99 14 12992 10580 79720802

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC N05BA05 NERVOUS SYSTEM
PSYCHOLEPTICS
ANXIOLYTICS
Benzodiazepine derivatives
FDA CS M0002356 Benzodiazepines
CHEBI has role CHEBI:35474 anti-anxiety agents
CHEBI has role CHEBI:35623 anticonvulsants
CHEBI has role CHEBI:50266 Prodrugs
CHEBI has role CHEBI:50268 GABA modulators
MeSH PA D014151 Anti-Anxiety Agents
MeSH PA D000927 Anticonvulsants
MeSH PA D002491 Central Nervous System Agents
MeSH PA D002492 Central Nervous System Depressants
MeSH PA D018682 GABA Agents
MeSH PA D018757 GABA Modulators
MeSH PA D018377 Neurotransmitter Agents
MeSH PA D011619 Psychotropic Drugs
MeSH PA D014149 Tranquilizing Agents
FDA EPC N0000175694 Benzodiazepine

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Anxiety indication 48694002
Alcohol withdrawal syndrome indication 191480000
Partial Epilepsy Treatment Adjunct indication
Suicidal thoughts contraindication 6471006
Alcohol intoxication contraindication 25702006
Depressive disorder contraindication 35489007
Substance abuse contraindication 66214007
Psychotic disorder contraindication 69322001
Sleep apnea contraindication 73430006 DOID:0050847
Kidney disease contraindication 90708001 DOID:557
Hypoalbuminemia contraindication 119247004
Disease of liver contraindication 235856003 DOID:409
Anemia contraindication 271737000 DOID:2355
Pregnancy, function contraindication 289908002
Severe chronic obstructive pulmonary disease contraindication 313299006
Angle-closure glaucoma contraindication 392291006 DOID:13550
Central nervous system depression contraindication 418072004




๐Ÿถ Veterinary Drug Use

None

๐Ÿถ Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 3.55 acidic
pKa2 13.86 acidic
pKa3 2.31 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
GABA-A receptor alpha-1/beta-2/gamma-2 Ion channel POSITIVE ALLOSTERIC MODULATOR EC50 7.47 WOMBAT-PK CHEMBL
GABA-A receptor alpha-2/beta-3/gamma-2 Ion channel POSITIVE ALLOSTERIC MODULATOR WOMBAT-PK CHEMBL
GABA-A receptor alpha-3/beta-3/gamma-2 Ion channel POSITIVE ALLOSTERIC MODULATOR WOMBAT-PK CHEMBL
GABA-A receptor alpha-5/beta-3/gamma-2 Ion channel POSITIVE ALLOSTERIC MODULATOR WOMBAT-PK CHEMBL

External reference:

IDSource
D00694 KEGG_DRUG
5991-71-9 SECONDARY_CAS_RN
23887-31-2 SECONDARY_CAS_RN
2353 RXNORM
4018712 VANDF
4019688 VANDF
C0008174 UMLSCUI
CHEBI:59590 CHEBI
CHEMBL1213252 ChEMBL_ID
CHEMBL2106085 ChEMBL_ID
CHEMBL2096631 ChEMBL_ID
DB00628 DRUGBANK_ID
2809 PUBCHEM_CID
7548 IUPHAR_LIGAND_ID
388 MMSL
4481 MMSL
d00198 MMSL
001456 NDDF
001457 NDDF
001458 NDDF
371349001 SNOMEDCT_US
387453004 SNOMEDCT_US
39815009 SNOMEDCT_US
D003009 MESH_DESCRIPTOR_UI
2224 INN_ID
MS63G8NQUI UNII

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Clorazepate Dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 0378-0030 TABLET 3.75 mg ORAL ANDA 19 sections
Clorazepate Dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 0378-0040 TABLET 7.50 mg ORAL ANDA 19 sections
Clorazepate Dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 0378-0070 TABLET 15 mg ORAL ANDA 19 sections
CLORAZEPATE DIPOTASSIUM Human Prescription Drug Label 1 13107-319 TABLET 3.75 mg ORAL ANDA 26 sections
CLORAZEPATE DIPOTASSIUM Human Prescription Drug Label 1 13107-319 TABLET 3.75 mg ORAL ANDA 26 sections
CLORAZEPATE DIPOTASSIUM Human Prescription Drug Label 1 13107-319 TABLET 3.75 mg ORAL ANDA 26 sections
CLORAZEPATE DIPOTASSIUM Human Prescription Drug Label 1 13107-320 TABLET 7.50 mg ORAL ANDA 26 sections
CLORAZEPATE DIPOTASSIUM Human Prescription Drug Label 1 13107-320 TABLET 7.50 mg ORAL ANDA 26 sections
CLORAZEPATE DIPOTASSIUM Human Prescription Drug Label 1 13107-320 TABLET 7.50 mg ORAL ANDA 26 sections
CLORAZEPATE DIPOTASSIUM Human Prescription Drug Label 1 13107-321 TABLET 15 mg ORAL ANDA 26 sections
CLORAZEPATE DIPOTASSIUM Human Prescription Drug Label 1 13107-321 TABLET 15 mg ORAL ANDA 26 sections
CLORAZEPATE DIPOTASSIUM Human Prescription Drug Label 1 13107-321 TABLET 15 mg ORAL ANDA 26 sections
Clorazepate Dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 21695-433 TABLET 3.75 mg ORAL ANDA 20 sections
Clorazepate Dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 21695-434 TABLET 7.50 mg ORAL ANDA 20 sections
Clorazepate Dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 43063-030 TABLET 15 mg ORAL ANDA 19 sections
Clorazepate Dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 43063-030 TABLET 15 mg ORAL ANDA 19 sections
Clorazepate Dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 43063-893 TABLET 15 mg ORAL ANDA 24 sections
Clorazepate Dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 51672-4042 TABLET 3.75 mg ORAL ANDA 24 sections
Clorazepate Dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 51672-4043 TABLET 7.50 mg ORAL ANDA 24 sections
Clorazepate Dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 51672-4044 TABLET 15 mg ORAL ANDA 24 sections
TranxeneT-Tab HUMAN PRESCRIPTION DRUG LABEL 1 55292-302 TABLET 7.50 mg ORAL NDA 19 sections
TranxeneT-Tab HUMAN PRESCRIPTION DRUG LABEL 1 55292-304 TABLET 7.50 mg ORAL NDA 19 sections
Clorazepate Dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 60505-4754 TABLET 3.75 mg ORAL ANDA 19 sections
Clorazepate Dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 60505-4755 TABLET 7.50 mg ORAL ANDA 19 sections
Clorazepate Dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 60505-4756 TABLET 15 mg ORAL ANDA 19 sections
Clorazepate dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 63304-552 TABLET 3.75 mg ORAL ANDA 16 sections
Clorazepate dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 63304-553 TABLET 7.50 mg ORAL ANDA 16 sections
Clorazepate dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 63304-554 TABLET 15 mg ORAL ANDA 16 sections
Clorazepate dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 67046-904 TABLET 7.50 mg ORAL ANDA 16 sections
Clorazepate Dipotassium HUMAN PRESCRIPTION DRUG LABEL 1 67046-906 TABLET 7.50 mg ORAL ANDA 20 sections